Venlafaxine withdrawal syndrome.
Macbeth
R
R
Rajagopalan
M
M
D003511:Cyclohexanols / Q000009:adverse effects*; D003866:Depressive Disorder / Q000628:therapy; D004565:Electroconvulsive Therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D009325:Nausea / Q000139:chemically induced*; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects*; D013375:Substance Withdrawal Syndrome; D000069470:Venlafaxine Hydrochloride
D003511:Cyclohexanols; D017367:Selective Serotonin Reuptake Inhibitors; D000069470:Venlafaxine Hydrochloride